Dr. Ajay Hooda, M.D

NPI: 1649414921
Total Payments
$5,967
2024 Payments
$743.39
Companies
23
Transactions
308
Medicare Patients
320
Medicare Billing
$44,986

Payment Breakdown by Category

Food & Beverage$5,967 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,967 308 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $1,367 76 $0 (2024)
E.R. Squibb & Sons, L.L.C. $1,234 72 $0 (2024)
PFIZER INC. $639.43 29 $0 (2023)
Allergan, Inc. $566.24 28 $0 (2020)
Novartis Pharmaceuticals Corporation $408.68 22 $0 (2024)
ABBVIE INC. $363.51 16 $0 (2024)
Alexion Pharmaceuticals, Inc. $310.65 12 $0 (2023)
AstraZeneca Pharmaceuticals LP $170.32 10 $0 (2022)
Gilead Sciences, Inc. $142.23 7 $0 (2023)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $112.52 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $743.39 35 Janssen Pharmaceuticals, Inc ($186.31)
2023 $1,122 53 Janssen Pharmaceuticals, Inc ($369.86)
2022 $1,021 54 E.R. Squibb & Sons, L.L.C. ($322.51)
2021 $1,089 55 Janssen Pharmaceuticals, Inc ($252.73)
2020 $382.36 24 E.R. Squibb & Sons, L.L.C. ($138.84)
2019 $539.72 28 PFIZER INC. ($173.80)
2018 $513.39 30 PFIZER INC. ($145.94)
2017 $555.74 29 Allergan Inc. ($318.46)

All Payment Transactions

308 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
12/19/2024 ABBVIE INC. TEFLARO (Drug), AVYCAZ, DALVANCE Food and Beverage In-kind items and services $24.96 General
Category: ANTI-INFECTIVE
12/16/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.01 General
Category: Gastroenterology
12/16/2024 EVOKE PHARMA, INC. GIMOTI (Drug) Food and Beverage In-kind items and services $15.03 General
Category: Gastroenterology
11/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.21 General
Category: Gastroenterology
10/14/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $22.09 General
Category: Obesity
10/09/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.01 General
Category: Gastroenterology
10/07/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $22.09 General
Category: Obesity
10/03/2024 ABBVIE INC. AVYCAZ (Drug), TEFLARO, DALVANCE Food and Beverage In-kind items and services $19.25 General
Category: ANTI-INFECTIVE
09/05/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $21.13 General
Category: Cardiovascular & Metabolism
08/19/2024 AIMMUNE THERAPEUTICS, INC. VOWST (Biological) Food and Beverage In-kind items and services $34.14 General
Category: GI
08/08/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $30.45 General
Category: CRITICAL CARE
08/05/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $21.13 General
Category: Cardiovascular & Metabolism
07/25/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $10.60 General
Category: Electromedical and Electrotherapeutic Apparatus
07/23/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $23.24 General
Category: Cardiovascular & Metabolism
07/19/2024 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $14.41 General
Category: INFECTIOUS DISEASE
06/26/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $22.14 General
Category: Cardiovascular & Metabolism
06/20/2024 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $24.90 General
Category: ANTI-INFECTIVE
05/23/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $20.92 General
Category: Cardiology/Vascular Diseases
05/16/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $23.09 General
Category: Cardiology/Vascular Diseases
05/13/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.02 General
Category: Gastroenterology
05/06/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.99 General
Category: Cardiovascular & Metabolism
04/24/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.91 General
Category: Cardiovascular & Metabolism
04/03/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.27 General
Category: Gastroenterology
03/28/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $17.48 General
Category: Cardiovascular
03/25/2024 Merck Sharp & Dohme LLC DIFICID (Drug), ZERBAXA Food and Beverage In-kind items and services $24.59 General
Category: INFECTIOUS DISEASE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 1 25 26 $5,200 $1,510
2021 2 29 118 $24,180 $6,713
2020 6 266 704 $146,410 $36,763
Total Patients
320
Total Services
848
Medicare Billing
$44,986
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 25 26 $5,200 $1,510 29.0%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 12 96 $19,680 $5,419 27.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 17 22 $4,500 $1,294 28.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 68 292 $59,860 $12,709 21.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 71 181 $36,300 $10,740 29.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 33 63 $17,955 $5,133 28.6%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 49 49 $14,700 $4,373 29.7%
99217 Hospital observation care on day of discharge Facility 2020 33 34 $6,970 $1,927 27.6%
99212 Established patient office or other outpatient visit, typically 10 minutes Facility 2020 12 85 $10,625 $1,880 17.7%

About Dr. Ajay Hooda, M.D

Dr. Ajay Hooda, M.D is a Hospitalist healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2009. The National Provider Identifier (NPI) number assigned to this provider is 1649414921.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ajay Hooda, M.D has received a total of $5,967 in payments from pharmaceutical and medical device companies, with $743.39 received in 2024. These payments were reported across 308 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,967).

As a Medicare-enrolled provider, Hooda has provided services to 320 Medicare beneficiaries, totaling 848 services with total Medicare billing of $44,986. Data is available for 3 years (2020–2022), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Hospitalist
  • Location Baltimore, MD
  • Active Since 04/30/2009
  • Last Updated 07/23/2010
  • Taxonomy Code 208M00000X
  • Entity Type Individual
  • NPI Number 1649414921

Products in Payments

  • ELIQUIS (Drug) $1,521
  • XARELTO (Drug) $1,367
  • DALVANCE (Drug) $500.08
  • TEFLARO (Drug) $329.93
  • ENTRESTO (Drug) $323.72
  • CAMZYOS (Drug) $170.91
  • Soliris (Drug) $169.31
  • BRILINTA (Drug) $149.21
  • XIFAXAN (Drug) $112.52
  • AMPLATZER (Device) $92.66
  • DIFICID (Drug) $90.93
  • CHANTIX (Drug) $90.48
  • LEQVIO (Drug) $84.96
  • JARDIANCE (Drug) $84.71
  • AVYCAZ (Drug) $69.20
  • OPSUMIT (Drug) $64.40
  • LifeVest (Device) $62.18
  • ULTOMIRIS (Biological) $44.30
  • Wegovy (Drug) $44.18
  • PANHEMATIN (Drug) $38.97

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hospitalist Doctors in Baltimore